Resources | Library

The Kalderos 340B rebate model in action

Blue, yellow, red and green colors swirled together with white print

340B Pay is the first-of-its-kind cloud-based solution that directly connects covered entities and manufacturers to request and receive 340B rebates, bringing a new level of ease and efficiency to a 30-year-old process.

A recent report from healthcare research firm 3 Axis Advisors provides the most complete picture to date of the operational impact that a 340B rebate model would have on covered entities. 3 Axis Advisors is a highly specialized consultancy with particular expertise in identifying U.S. drug supply chain inefficiencies and cost drivers.

A thorough analysis of the advantages that covered entities would experience is available in the whitepaper, "The Kalderos 340B rebate model in action."


Key findings in the 3 Axis report:


  • Covered entities would receive faster payments from contract pharmacy dispenses.

  • Covered entities would carry lower inventory costs.

  • When rebates are based on WAC instead of contract pharmacy reimbursements tied to discounted AWP, covered entities gain access to incrementally higher revenue opportunities.

Fill out the form below to download whitepaper now.

By submitting this form, I agree that Kalderos may contact me at the email address or phone number above to tell me about its services.